Tobacco abstinence rates were statistically significantly higher in the extended-therapy group than the standard-therapy group at 24 weeks. However, similar numbers of participants in both groups (about 14%) were abstinent at 52 weeks. Reported side effects, such as nausea, skin redness, and sleep problems, were mostly similar between groups. No serious life-threatening adverse events were attributed to extended therapy.